Insulet Stock: Is Wall Street Bullish or Bearish?

With a market cap of $23.5 billion, Insulet Corporation (PODD) is a leading medical device company specializing in innovative insulin-delivery technology based in Acton, Massachusetts. Its flagship product, the Omnipod system, is a tubeless, wearable patch pump that provides continuous insulin delivery without the need for traditional tubes or multiple daily injections. 

Shares of PODD have significantly outpaced the broader market over the past 52 weeks. PODD stock has soared 32.2% over this period, while the broader S&P 500 Index ($SPX) has gained 14.3%. However, shares of PODD are up 6.3% on a YTD basis, compared to SPX’s 9.5% rise.